Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6889426

NCCCNc1cccc2c1C(=O)c1ccccc1C2=O.O=C(O)C(F)(F)F

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.56
KMT2A Q03164 4/20 0.56
MAPT P10636 4/20 0.56
L3MBTL1 Q9Y468 4/20 0.56
ALDH1A1 P00352 4/20 0.56
POLB P06746 3/20 0.56
BLM P54132 2/20 0.56
EGFR P00533 2/20 0.56
MAPK1 P28482 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
LMNA P02545 2/20 0.56
RAD52 P43351 2/20 0.56
HTT P42858 1/20 0.56
RECQL P46063 1/20 0.56
NPSR1 Q6W5P4 1/20 0.56
NSD2 O96028 2/20 0.51
FGB P02675 1/20 0.51
MMP14 P50281 1/20 0.51
RXFP1 Q9HBX9 1/20 0.48
MAOA P21397 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL6888365 0.89 MAPT (0.60) MEN1KMT2AMAPTL3MBTL1ALDH1A1
SCHEMBL109325 0.88 MEN1 (0.64) MEN1KMT2AMAPTL3MBTL1ALDH1A1
Hydrochloric Acid SCHEMBL6577424 0.87 MAPT (0.63) MEN1KMT2AMAPTL3MBTL1ALDH1A1
Trifluoroacetic Acid SCHEMBL6665362 0.87 MEN1 (0.50) MEN1KMT2AMAPTL3MBTL1ALDH1A1
Trifluoroacetic Acid SCHEMBL6662164 0.85 MEN1 (0.48) MEN1KMT2AMAPTL3MBTL1ALDH1A1
SCHEMBL8602072 0.84 MAPT (0.63) MEN1KMT2AMAPTL3MBTL1ALDH1A1
SCHEMBL20334284 0.84 NSD2 (0.63) MEN1KMT2AMAPTL3MBTL1ALDH1A1
Trifluoroacetic Acid SCHEMBL6660175 0.83 MAPT (0.49) MEN1KMT2AMAPTL3MBTL1ALDH1A1
Trifluoroacetic Acid SCHEMBL6662414 0.83 MAPT (0.49) MEN1KMT2AMAPTL3MBTL1ALDH1A1
Hydrochloric Acid SCHEMBL8603274 0.83 MAPT (0.61) MEN1KMT2AMAPTL3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040248765-A1 Tumour targeting prodrugs activated by metallo matrixproteinases COURT OF NAPIER UNIVERSITY, THE (GB) 2004-12-09 US disclosed
EP-1366064-A1 TUMOUR TARGETING PRODRUGS ACTIVATED BY METALLO MATRIXPROTEINASES The Court of Napier University (GB) 2003-12-03 EP disclosed
WO-2002072620-A1 TUMOUR TARGETING PRODRUGS ACTIVATED BY METALLO MATRIXPROTEINASES THE COURT OF NAPIER UNIVERSITY (GB) 2002-09-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040248765-A1 Tumour targeting prodrugs activated by metallo matrixproteinases MMP2, MMP26, ADAM17 MEN1 223/4885KMT2A 1487/4885MAPT 4871/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.